Epidemiology of inclusion body myositis in the Netherlands:: A nationwide study
Epidemiology of inclusion body myositis in the Netherlands:: A nationwide study
复制标题
DOI：
10.1212/wnl.55.9.1385
复制
发表时间：
2000-11-14
期刊：
影响因子：
9.9
通讯作者：
Wintzen, AR
中科院分区：
文献类型：
--
作者：
Badrising, UA;Maat-Schieman, M;Wintzen, AR
关于包涵体肌炎（IBM）的流行病学数据很少，而且可能有偏见，因为它们来自更大的神经肌肉中心。目前的全国性合作横断面研究，最终在1999年7月1日，导致76例IBM患者的识别和建立的患病率为4.9例IBM每百万居民在荷兰。一些差异表明，这可能是低估。在诊断IBM时，最常见的陷阱是误诊为多发性肌炎或运动神经元疾病。
Epidemiologic data on inclusion body myositis (IBM) are scarce, and possibly biased, because they are derived from larger neuromuscular centers. The present nationwide collaborative cross-sectional study, which culminated on July 1, 1999, resulted in identification of 76 patients with IBM and the establishment of a prevalence of 4.9 patients with IBM per million inhabitants in the Netherlands. Several discrepancies suggest that this may be an underestimation. The most frequently identified pitfall in diagnosing IBM was an erroneous diagnosis of polymyositis or motor neuron disease.